Region-specific organoids (cerebral, midbrain, glia-enriched MS organoids) capture multicellular phenotypes—Aβ/tau and synaptic changes (AD), dopaminergic vulnerability and network activity (PD), oligodendrocyte maturation and myelination (MS)—with electrophysiology and multi-omics endpoints. The gene discussed is MAPT; the disease is Alzheimer disease.